Fragile X checklists: A meta-analysis and development of a simplified universal clinical checklist.

[en] BACKGROUND: Clinical checklists available have been developed to assess the risk of a positive Fragile X syndrome but they include relatively small sample sizes. Therefore, we carried out a meta-analysis that included statistical pooling of study results to obtain accurate figures on the prevalence of clinical predictors of Fragile X syndrome among patients with intellectual disability, thereby helping health professionals to improve their referrals for Fragile X testing. METHODS: All published studies consisting of cytogenetic and/or molecular screening for fragile X syndrome among patients with intellectual disability, were eligible for the meta-analysis. All patients enrolled in clinical checklists trials of Fragile X syndrome were eligible for this review, with no exclusion based on ethnicity or age. Odds ratio values, with 95% confidence intervals as well as Cronbach coefficient alpha, was reported to assess the frequency of clinical characteristics in subjects with intellectual disability with and without the fragile X mutation to determine the most discriminating. RESULTS: The following features were strongly associated with Fragile X syndrome: skin soft and velvety on the palms with redundancy of skin on the dorsum of hand [OR: 16.85 (95% CI 10.4-27.3; alpha:0.97)], large testes [OR: 7.14 (95% CI 5.53-9.22; alpha: 0.80)], large and prominent ears [OR: 18.62 (95% CI 14.38-24.1; alpha: 0.98)], pale blue eyes [OR: 8.97 (95% CI 4.75-16.97; alpha: 0.83)], family history of intellectual disability [OR: 3.43 (95% CI 2.76-4.27; alpha: 0.81)] as well as autistic-like behavior [OR: 3.08 (95% CI 2.48-3.83; alpha: 0.77)], Flat feet [OR: 11.53 (95% CI 6.79-19.56; alpha:0.91)], plantar crease [OR: 3.74 (95% CI 2.67-5.24; alpha: 0.70)]. We noted a weaker positive association between transverse palmar crease [OR: 2.68 (95% CI 1.70-4.18; alpha: 0.51)], elongated face [OR: 3.69 (95% CI 2.84-4.81; alpha: 0.63)]; hyperextensible metacarpo-phalangeal joints [OR: 2.68 (95% CI 2.15-3.34; alpha: 0.57)] and the Fragile X syndrome. CONCLUSION: This study has identified the highest risk features for patients with Fragile X syndrome that have been used to design a universal clinical checklist.

Disciplines :

Genetics & genetic processes

Author, co-author :

Lubala, Toni Kasole

Lumaka Zola, Aimé ; Université de Liège - ULiège > Human Genetics

Kanteng, Gray

Mutesa, Leon

Mukuku, Olivier

Wembonyama, Stanislas

Hagerman, Randi

Luboya, Oscar Numbi

Lukusa Tshilobo, Prosper

Language :

English

Title :

Fragile X checklists: A meta-analysis and development of a simplified universal clinical checklist.

Publication date :

2018

Journal title :

Molecular Genetics and Genomic Medicine

eISSN :

2324-9269

Publisher :

Wiley, Hoboken, United States - New Jersey

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 18 January 2019

Statistics

Number of views

60 (3 by ULiège)

Number of downloads

2 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Arvio, M., Peippo, M., & Simola, K. O. (1997). Applicability of a checklist for clinical screening of the fragile X syndrome. Clinical genetics, 52(4), 211–215.
Behery, A. K. (2008). Fragile x-syndrome: Clinical and molecular studies. The Journal of the Egyptian Public Health Association, 83(3–4), 273–283.
Bellavance, J., & Morin, D. (2017). French translation and validation of a fragile X syndrome screening checklist. Journal of Intellectual & Developmental Disability, 6, 1–6. https://doi.org/10.3109/13668250.2017.1310807
Boy, R., Correia, P. S., Llerena, J. C., Machado-Ferreira, M. D., & Pimentel, M. M. G. (2001). Fragile X syndrome confirmed by molecular analysis: A case-control study with pre and post-puberal patients. Arquivos de Neuro-Psiquiatria, 59(1), 83–88. https://doi.org/10.1590/S0004-282X2001000100017
Butler, M. G., Brunschwig, A., Miller, L. K., & Hagerman, R. J. (1992). Standards for selected anthropometric measurements in males with the fragile X syndrome. [Comparative Study Research Support, Non-U.S. Gov't]. Pediatrics, 89(6 Pt 1), 1059–1062.
Butler, M. G., Mangrum, T., Gupta, R., & Singh, D. N. (1991). A 15-item checklist for screening mentally retarded males for the fragile X syndrome. [Research Support, Non-U.S. Gov't]. Clinical Genetics, 39(5), 347–354.
Christofolini, D. M., Abbud, E. M., Lipay, M. V., Costa, S. S., Vianna-Morgante, A. M., Bellucco, F. T., … Melaragno, M. I. (2009). Evaluation of clinical checklists for fragile X syndrome screening in Brazilian intellectually disabled males: Proposal for a new screening tool. [Research Support, Non-U.S. Gov't]. Journal of Intellectual Disabilities: JOID, 13(3), 239–248. https://doi.org/10.1177/1744629509348429
Crawford, D. C., Meadows, K. L., Newman, J. L., Taft, L. F., Scott, E., Leslie, M., … Sherman, S. L. (2002). Prevalence of the fragile X syndrome in African-Americans. [Research Support, U.S. Gov't, P.H.S.]. American Journal of Medical Genetics, 110(3), 226–233. https://doi.org/10.1002/ajmg.10427
Davids, J. R., Hagerman, R. J., & Eilert, R. E. (1990). Orthopaedic aspects of fragile-X syndrome. [Review]. The Journal of Bone and Joint Surgery. American Volume, 72(6), 889–896. https://doi.org/10.2106/00004623-199072060-00015
Essop, F. B., & Krause, A. (2013). Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: A 20-year review. South African medical journal, 103(12 Suppl 1), 994–998. https://doi.org/10.7196/samj.7144
Giangreco, C. A., Steele, M. W., Aston, C. E., Cummins, J. H., & Wenger, S. L. (1996). A simplified six-item checklist for screening for fragile X syndrome in the pediatric population. The Journal of Pediatrics, 129(4), 611–614. https://doi.org/10.1016/S0022-3476(96)70130-0
Guo, Y., Chai, J., Yao, D., Zhang, S., Huang, S., & Zhao, S. (2000). [A simplified six-item checklist for screening of fragile X syndrome]. [Research Support, Non-U.S. Gov't]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 22(1), 85–87.
Guruju, M. R., Lavanya, K., Thelma, B. K., Sujatha, M., OmSai, V. R., Nagarathna, V., … Anandaraj, M. P. (2009). Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India. Journal of clinical neuroscience, 16(10), 1305–1310. https://doi.org/10.1016/j.jocn.2008.12.018
Hagerman, R. J., Amiri, K., & Cronister, A. (1991). Fragile X checklist. [Research Support, Non-U.S. Gov't]. American journal of medical genetics, 38(2–3), 283–287. https://doi.org/10.1002/(ISSN)1096-8628
Hagerman, R., & Hagerman, P. (2013). Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. [Research Support, N.I.H., Extramural Review]. The Lancet. Neurology, 12(8), 786–798. https://doi.org/10.1016/S1474-4422(13)70125-X
Kanwal, M., Alyas, S., Afzal, M., Mansoor, A., Abbasi, R., Tassone, F., Mazhar, K. (2015). Molecular diagnosis of Fragile X syndrome in subjects with intellectual disability of unknown origin: Implications of its prevalence in regional Pakistan. [Research Support, Non-U.S. Gov't]. PLoS ONE, 10(4), e0122213. https://doi.org/10.1371/journal.pone.0122213
Lachiewicz, A. M., Dawson, D. V., & Spiridigliozzi, G. A. (2000). Physical characteristics of young boys with fragile X syndrome: Reasons for difficulties in making a diagnosis in young males. [Research Support, Non-U.S. Gov't]. American Journal of Medical Genetics, 92(4), 229–236. https://doi.org/10.1002/(ISSN)1096-8628
Laing, S., Partington, M., Robinson, H., & Turner, G. (1991). Clinical screening score for the fragile X (Martin-Bell) syndrome. [Comparative Study]. American Journal of Medical Genetics, 38(2–3), 256–259. https://doi.org/10.1002/(ISSN)1096-8628
Limprasert, P., Ruangdaraganon, N., Vasiknanonte, P., Sura, T., Jaruratanasirikul, S., Sriwongpanich, N., & Sriplung, H. (2000). A clinical checklist for fragile X syndrome: Screening of Thai boys with developmental delay of unknown cause. [Comparative Study Research Support, Non-U.S. Gov't]. Journal of the Medical Association of Thailand, 83(10), 1260–1266.
Lumaka, A., Cosemans, N., Lulebo Mampasi, A., Mubungu, G., Mvuama, N., Lubala, T., … Devriendt, K. (2017). Facial dysmorphism is influenced by ethnic background of the patient and of the evaluator. Clinical genetics, 92(2), 166–171. https://doi.org/10.1111/cge.12948
Maes, B., Fryns, J. P., Ghesquiere, P., & Borghgraef, M. (2000). Phenotypic checklist to screen for fragile X syndrome in people with mental retardation. Mental retardation, 38(3), 207–215. https://doi.org/10.1352/0047-6765(2000)038<0207:PCTSFF>2.0.CO;2
Mandel, J. L., & Chelly, J. (2004). Monogenic X-linked mental retardation: Is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations. [Research Support, Non-U.S. Gov't]. European Journal of Human Genetics: EJHG, 12(9), 689–693. https://doi.org/10.1038/sj.ejhg.5201247
Peprah, E. K., Allen, E. G., Williams, S. M., Woodard, L. M., & Sherman, S. L. (2010). Genetic diversity of the fragile X syndrome gene (FMR1) in a large Sub-Saharan West African population. [Comparative Study Research Support, N.I.H., Extramural]. Annals of human genetics, 74(4), 316–325. https://doi.org/10.1111/j.1469-1809.2010.00582.x
Settin, A. A., Al-Haggar, M. S., Al-Baz, R. A., Al-Aiouty, M. M., & Hafez, M. M. (2005). Screening of mentally handicapped Egyptian children for fragile X syndrome using clinical, cytogenetic and molecular approaches. Journal of Pediatric Neurology, 3(4), 8. https://doi.org/10.1055/s-0035-1557288
Sherman, S. L., Jacobs, P. A., Morton, N. E., Froster-Iskenius, U., Howard-Peebles, P. N., Nielsen, K. B., … Watson, M. (1985). Further segregation analysis of the fragile X syndrome with special reference to transmitting males. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Human genetics, 69(4), 289–299. https://doi.org/10.1007/BF00291644
van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003). Updated method guidelines for systematic reviews in the cochrane collaboration back review group. [Comparative Study Research Support, Non-U.S. Gov't]. Spine, 28(12), 1290–1299. https://doi.org/10.1097/01.BRS.0000065484.95996.AF
de Vries, B. B., Halley, D. J., Oostra, B. A., & Niermeijer, M. F. (1998). The fragile X syndrome. [Research Support, Non-U.S. Gov't Review]. Journal of Medical Genetics, 35(7), 579–589. https://doi.org/10.1136/jmg.35.7.579